Gene · 3047
Papers4,047
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,081 to 1,100 of 4,047
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Induction of therapeutic levels of HbF in genome-edited primary β0 39-thalassaemia haematopoietic stem and progenitor cells. | Br J Haematol | 2021 | 33216968 | PubTator, text mining | PubMed |
| Getting blood out of a stone: Identification and management of patients with poor hematopoietic cell mobilization. | Blood Rev | 2021 | 33213986 | PubTator, text mining | PubMed |
| Benserazide as a potential novel fetal hemoglobin inducer: an observational study in non-carriers of hemoglobin disorders. | Blood Cells Mol Dis | 2021 | 33202326 | PubTator, text mining | PubMed |
| Monoterpenes as therapeutic candidates to induce fetal hemoglobin synthesis and up-regulation of gamma-globin gene: An in vitro and in vivo investigation. | Eur J Pharmacol | 2021 | 33137331 | PubTator, text mining | PubMed |
| Clinically relevant updates of the HbVar database of human hemoglobin variants and thalassemia mutations. | Nucleic Acids Res | 2021 | 33125055 | PubTator, text mining | PubMed |
| Human Noroviruses Attach to Intestinal Tissues of a Broad Range of Animal Species. | J Virol | 2021 | 33115870 | PubTator, text mining | PubMed |
| Potent and orally active purine-based fetal hemoglobin inducers for treating β-thalassemia and sickle cell disease. | Eur J Med Chem | 2021 | 33109398 | PubTator, text mining | PubMed |
| Lysophosphatidic acid receptors 2 and 3 regulate erythropoiesis at different hematopoietic stages. | Biochim Biophys Acta Mol Cell Biol Lipids | 2021 | 33035680 | PubTator, text mining | PubMed |
| In Vivo HSC Gene Therapy Using a Bi-modular HDAd5/35++ Vector Cures Sickle Cell Disease in a Mouse Model. | Mol Ther | 2021 | 32949495 | PubTator, text mining | PubMed |
| Maternal Psychological Resilience During Pregnancy and Newborn Telomere Length: A Prospective Study. | Am J Psychiatry | 2021 | 32911996 | PubTator, text mining | PubMed |
| Changing the Clinical Paradigm of Hydroxyurea Treatment for Sickle Cell Anemia Through Precision Medicine. | Clin Pharmacol Ther | 2021 | 32869281 | PubTator, text mining | PubMed |
| Fetal hemoglobin rescues ineffective erythropoiesis in sickle cell disease. | Haematologica | 2021 | 32855279 | PubTator, text mining | PubMed |
| Curative gene therapies for rare diseases. | J Community Genet | 2021 | 32803721 | PubTator, text mining | PubMed |
| In vitro and in vivo induction of fetal hemoglobin with a reversible and selective DNMT1 inhibitor. | Haematologica | 2021 | 32586904 | PubTator, text mining | PubMed |
| Hemoglobin switching in mice carrying the Klf1Nan variant. | Haematologica | 2021 | 32467144 | PubTator, text mining | PubMed |
| Advances in genome editing: the technology of choice for precise and efficient β-thalassemia treatment. | Gene Ther | 2021 | 32355226 | PubTator, text mining | PubMed |
| The Coup-TFII orphan nuclear receptor is an activator of the γ-globin gene. | Haematologica | 2021 | 32107331 | PubTator, text mining | PubMed |
| Quantitative proteomic profiling of white matter in cases of cerebral amyloid angiopathy reveals upregulation of extracellular matrix proteins and clusterin. | Free Neuropathol | 2020 | 37283687 | PubTator, text mining | PubMed |
| A Small Key for a Heavy Door: Genetic Therapies for the Treatment of Hemoglobinopathies. | Front Genome Ed | 2020 | 34713239 | PubTator, text mining | PubMed |
| β-Hemoglobinopathies: The Test Bench for Genome Editing-Based Therapeutic Strategies. | Front Genome Ed | 2020 | 34713219 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3047/papers?page=55